Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microboosting Atazanavir with Low Dose Ritonavir in HIV
NCT02034838Phase 1Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jan 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ritonavir in human immunodeficiency virus infection (HIV), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Pharmacokinetics at 9 days. Started Jan 2014; status: completed.
02
Drugs
ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02034838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034838.